Table 4. NEI VFQ-25 overall composite score and subscale scores (mean ± SD).

		GH	GV	OP	NA	DA	VSSF	VSMH	VSRD	VSD	D	CV	PV	OCSa
		(n = 55)	(n = 55)	(n = 55)	(n = 55)	(n = 54)	(n = 55)	(n = 55)	(n = 55)	(n = 55)	(n = 45)	(n = 50)	(n = 53)	(n = 55)
Total group	(n = 55)	60.5±21.3	71.3±12.0	88.4±15.2	85.6±13.8	86.1±12.6	98.4±4.8	87.6±14.7	88.2±16.2	98.3±5.4	84.2±17.1	97.0±13.0	91.0±16.3	88.9±7.9
Gender	- Male (n = 40)	61.9±20.4	71.0±20.4	87.2±16.6	85.6±13.3	86.8±11.6	97.8±5.6	87.7±15.1	87.2±15.9	97.9±6.2	87.1±15.4	96.4±15.0	91.5±16.7	88.4±84
	- Female (n = 15)	56.7±24.3	72.0±12.6	91.7±10.2	85.6±15.6	83.9±15.5	100.0±0.0	87.5±14.0	90.8±17.3	99.4±2.2	75.0±19.7	98.3±6.5	90.0±15.8	89.8±6.8
	P-value	0.256	0.907	0.546	0.861	0.679	0.116	0.899	0.314	0.396	0.052	0.939	0.574	0.777
Family b	- Positive (n = 6)	58.3±25.8	63.3±15.1	93.8±10.5	77.8±16.4	81.9±6.3	97.9±5.1	83.3±10.9	87.5±15.8	100.0±0.0	83.3±18.0	100.0±0.0	83.4±25.8	85.24±9.0
	- Negative (n = 49)	60.7±21.0	72.2±11.4	87.8±15.6	86.6±13.4	86.6±13.2	98.5±4.9	88.1±15.1	88.3±16.4	98.1±5.7	84.3±17.3	96.6±13.8	92.0±14.8	89.18±7.8
	P-value	0.755	0.148	0.380	0.166	0.182	0.653	0.148	0.788	0.327	0.854	0.514	0.467	0.19
Lens (pre-op)	- Phakic (n = 37)	62.2±21.7	70.3±10.1	87.8±16.5	84.2±12.8	85.7±12.2	98.7±4.9	84.8±16.0	88.2±16.4	97.8±6.4	82.8±18.2	97.7±9.6	90.0±16.3	88.2±7.8
	- Pseudophakic (n = 18)	56.9±20.7	73.3±15.3	89.6±12.3	88.4±15.7	86.9±13.9	97.9±4.8	93.4±9.5	88.2±16.3	99.5±2.0	86.9±15.0	95.6±18.2	93.1±16.7	89.9±8.3
	P-value	0.376	0.390	0.907	0.138	0.530	0.370	0.012	0.960	0.258	0.451	0.980	0.331	0.212
Quadrants c	- 1–2 (n = 35)	58.6±19.1	72.0±11.1	91.4±13.5	87.6±12.7	86.9±11.8	99.3±2.9	90.6±9.6	92.1±13.6	98.8±3.6	85.4±18.1	96.9±13.8	90.4±17.4	90.0±6.7
	- 3–4 (n = 19)	61.8±24.1	69.5±13.9	82.2±16.8	81.6±15.6	84.6±14.5	96.7±7.0	82.9±20.6	80.3±18.3	97.4±7.8	81.6±15.7	97.1±12.1	91.7±14.9	86.4±9.8
	P-value	0.733	0.481	0.017	0.163	0.616	0.084	0.181	0.011	0.630	0.288	0.960	0.970	0.319
PVR	- Grade A (n = 30)	59.2±22.2	72.7±11.1	90.8±12.3	87.2±13.8	88.8±10.6	99.2±3.2	91.0±8.6	88.3±14.6	98.6±3.8	86.3±13.3	96.3±15.0	90.0±18.1	89.6±6.5
	- Grade B (n = 16)	60.9±15.7	71.3±14.5	85.2±16.6	85.4±15.4	86.1±9.8	96.9±7.2	87.9±11.7	88.3±18.5	99.5±2.1	80.8±22.2	96.4±13.4	90.0±15.8	88.1±9.0
	- Grade C (n = 8)	59.4±26.5	65.0±9.3	84.4±21.9	79.2±10.9	76.0±20.1	98.4±4.4	75.8±28.8	85.9±19.4	94.8±11.7	81.3±26.7	100.0±0.0	96.4±9.4	86.4±11.2
	P-value	0.866	0.235	0.486	0.227	0.159	0.440	0.347	0.848	0.400	0.955	0.737	0.650	0.899
Duration d	- ≤1 week (n = 29)	60.3±19.5	70.3±11.5	89.66±15.3	86.2±13.4	86.2±12.2	99.1±4.6	90.1±10.8	88.4±14.1	98.3±4.01	84.1±17.6	95.4±17.0	92.9±13.4	89.2±7.1
	-> 1 week (n = 26)	60.6±23.6	72.3±12.7	87.02±15.2	84.9±14.5	86.0±13.3	97.6±5.0	84.9±18.0	88.0±15.5	98.4±6.7	84.3±16.9	98.9±5.2	89.0±19.2	88.2±8.9
	P-value	0.875	0.746	0.338	0.815	0.874	0.075	0.244	0.708	0.322	0.934	0.620	0.628	0.781
Success rate	- Primary (n = 45)	58.9±21.4	72.0±12.4	89.7±13.1	87.2±13.8	87.0±12.2	98.6±4.8	89.9±10.9	88.1±15.1	98.7±3.5	87.2±12.9	97.0±13.8	92.1±15.0	89.9±6.7
	- Secondary (n = 10)	67.5±20.6	68.0±10.3	82.5±22.2	78.3±11.9	81.5±14.3	97.5±5.3	77.5±24.0	88.8±21.6	96.7±10.5	67.9±27.4	96.9±8.8	86.1±22.0	83.3±10.9
	P-value	0.229	0.313	0.104	0.039	0.255	0.333	0.072	0.506	0.865	0.085	0.440	0.480	0.053
Re-detached e	- 1 (n = 7)	64.3±19.7	68.6±10.7	94.6±6.7	79.8±14.3	81.9±14.4	98.2±4.7	88.4±10.5	91.1±23.6	100.0±0.0	75.0±27.6	95.0±11.2	92.9±18.9	88.1±8.0
	- 2 (n = 3)	75.0±25	66.7±11.5	54.2±19.1	75.0±0	80.6±17.3	95.8±7.2	52.1±29.5	83.3±19.1	88.9±19.2	50.0±23.6	100.0±0.0	62.5±17.7	72.0±8.8
	P-value	0.458	0.789	0.012	0.479	0.794	0.513	0.027	0.207	0.127	0.241	0.439	0.054	0.053
Technique	- Conventional (n = 10)	62.5±21.2	76.0±8.4	90.0±16.5	90.8±10	87.5±11.9	100.0±0.0	90.0±12.2	98.8±4.0	98.3±3.5	85.4±24.3	100.0±0.0	92.5±12.1	91.8±6.0
	- PPV (n = 45)	60.0±21.6	70.2±12.5	88.1±15.1	84.4±14.4	85.7±12.9	98.1±5.3	87.1±15.3	85.8±17	98.3±5.8	83.9±15.6	96.3±14.3	90.7±17.3	88.1±8.2
	P-value	0.847	0.121	0.554	0.235	0.856	0.226	0.472	0.014	0.497	0.322	0.408	0.953	0.209
TPPV & Band f	- Band (n = 18)	61.1±21.4	74.4±15.0	89.6±12.3	87.0±16.5	89.8±10.5	98.6±4.0	92.0±10.2	88.2±15.1	99.5±2.0	86.5±14.6	100.0±0.0	91.7±17.1	90.3±7.9
	- No band (n = 27)	59.3±22.1	67.4±9.8	87.0±16.8	82.7±12.9	83.2±13.8	97.7±6.0	83.8±17.3	84.3±18.2	97.5±7.2	81.9±16.4	93.8±18.4	90.0±17.7	86.6±8.3
	P-value	0.890	0.056	0.755	0.169	0.099	0.694	0.038	0.518	0.318	0.372	0.135	0.699	0.073
Tamponade g	- Short acting (n = 35)	59.3±21.1	72.6±12.0	91.8±10.9	87.1±13.5	85.6±18.6	98.6±4.0	91.6±8.2	86.4±16.4	99.1±3.4	84.8±20.1	96.9±13.8	91.2±17.3	89.8±6.7.7
	- Long acting (n = 10)	62.5±24.3	62.0±11.4	75.0±20.4	75.0±14.2	77.5±15.2	96.3±8.4	71.3±23.0	83.8±19.6	95.8±10.6	65.3±15.3	94.4±16.7	88.9±18.2	81.9±10.2
	P-value	0.788	0.041	0.012	0.021	0.061	0.657	<0.001	0.778	0.581	0.004	0.841	0.714	0.018
Lens (post-op)	- Phakic (n = 11)	59.1±16.9	74.6±9.3	85.2±21.5	92.4±8.7	87.1±12.0	97.7±7.5	90.3±11.0	90.9±15.9	98.5±3.4	81.3±23.0	95.5±12.6	90.9±12.6	89.8±8.6
	- Pseudophakic (n = 42)	61.3±22.2	71.0±12.7	89.6±13.5	84.9±13.9	86.9±11.8	98.8±3.7	88.2±14.2	87.2±16.7	98.2±6.0	84.8±15.9	97.4±16.2	92.5±16.2	88.6±7.8
	P-value	0.779	0.315	0.981	0.117	0.927	0.965	0.626	0.487	0.641	0.873	0.645	0.387	0.483

Nominal significant values are indicated in bold.

NEI VFQ-25: National Eye Institute Visual Functioning Questionnaire-25, SD: standard deviation, GH: General Health, GV: General vision, OP: Ocular pain, NA: Near activities, DA: Distance activities, VSSF: Vision Specific Social Functioning, VSMH: Vision Specific Mental Health, VSRD: Vision Specific Role Difficulties, VSD: Vision Specific Dependency, D: Driving, CV: Color Vision, PV: Peripheral Vision, OCS: Overall Composite Score, PVR: Proliferative vitreoretinopathy, PPV: Pars Plana Vitrectomy.

^aAverage of vision-targeted subscale scores, without GH.

^bFamily history of RRD.

^cNumbers of detached retinal quadrants at presentation.

^dDuration of macular detachment.

^eNumber of re-detachments.

^fPPV with or without an encircling band.

^gPostoperative tamponade after PPV; SF6 gas (short acting) versus C3F8 gas & silicon oil (long acting).